APA (7th ed.) Citation

Ledoult, E., Groh, M., Meresse, B., Dubois, R., Trauet, J., Toussaint, E., . . . Lefevre, G. (2024). Targeting CCR4 with mogamulizumab in refractory CD3-CD4+ lymphocytic-variant hypereosinophilic syndrome. Haematologica (Roma), 109(6), 1984-1988. https://doi.org/10.3324/haematol.2023.284429

Chicago Style (17th ed.) Citation

Ledoult, Emmanuel, et al. "Targeting CCR4 with Mogamulizumab in Refractory CD3-CD4+ Lymphocytic-variant Hypereosinophilic Syndrome." Haematologica (Roma) 109, no. 6 (2024): 1984-1988. https://doi.org/10.3324/haematol.2023.284429.

MLA (9th ed.) Citation

Ledoult, Emmanuel, et al. "Targeting CCR4 with Mogamulizumab in Refractory CD3-CD4+ Lymphocytic-variant Hypereosinophilic Syndrome." Haematologica (Roma), vol. 109, no. 6, 2024, pp. 1984-1988, https://doi.org/10.3324/haematol.2023.284429.